Passage Bio Appoints Thomas Kassberg to Leadership Team
Company Announcements

Passage Bio Appoints Thomas Kassberg to Leadership Team

Passage Bio ( (PASG) ) has provided an announcement.

Passage Bio, Inc. enhanced its leadership team by appointing Thomas Kassberg, a seasoned executive with a rich background in biotech, as a Class I director and member of the Audit Committee. Kassberg, who has been with Ultragenyx Pharmaceutical since 2011 and holds an M.B.A. from Kellogg School of Management, will receive stock options as part of his compensation, which will vest over a three-year period. His experience is expected to contribute significantly to the company’s strategic development.

For detailed information about PASG stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPassage Bio Presents Promising Data on PBFT02 Therapy
TheFlyPassage Bio delivered preclinical, interim data at ESGCT
TipRanks Auto-Generated NewsdeskPassage Bio Reveals Promising Gene Therapy Trial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App